If you are right zereal, which you may well be, it is another poor decision. The possibility of a SPP will continue to depress the share price, so that existing shareholders will be further diluted by a large percentage if any meaningful sum is expected to be raised. Future rises in share price back to a reasonable level will also be adversely affected if the number of issued shares is increased. Ruling out a SPP is a sure fire way to increase the current S.P.
- Forums
- ASX - By Stock
- AMI
- Ann: Chairman's Address to Shareholders - 2022 AGM
Ann: Chairman's Address to Shareholders - 2022 AGM, page-6
Featured News
Add AMI (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $287.5M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 16.5¢ | $370.6K | 2.197M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1063664 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 32089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1238163 | 0.165 |
15 | 1322214 | 0.160 |
8 | 685438 | 0.155 |
9 | 389849 | 0.150 |
4 | 206004 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 191074 | 5 |
0.175 | 878350 | 10 |
0.180 | 193162 | 4 |
0.185 | 546238 | 9 |
0.190 | 584201 | 9 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AMI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online